Imperial College London

ProfessorGrahamCooke

Faculty of MedicineDepartment of Infectious Disease

Vice Dean (Research); Professor of Infectious Diseases
 
 
 
//

Contact

 

g.cooke

 
 
//

Location

 

Infectious Diseases SectionMedical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Whitaker:2022:10.1038/s41467-022-29521-z,
author = {Whitaker, M and Elliott, J and Chadeau, M and Riley, S and Darzi, A and Cooke, G and Ward, H and Elliott, P},
doi = {10.1038/s41467-022-29521-z},
journal = {Nature Communications},
title = {Persistent COVID-19 symptoms in a community study of 606,434 people in England},
url = {http://dx.doi.org/10.1038/s41467-022-29521-z},
volume = {13},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Long COVID remains a broadly defined syndrome, with estimates of prevalence and duration varying widely. We use data from rounds 3–5 of the REACT-2 study (n=508,707; September 2020 – February 2021), a representative community survey of adults in England, and replication data from round 6 (n=97,717; May 2021) to estimate the prevalence and identify predictors of persistent symptoms lasting 12 weeks or more; and unsupervised learning to cluster individuals by reported symptoms. At 12 weeks in rounds 3–5, 37.7% experienced at least one symptom, falling to 21.6% in round 6. Female sex, increasing age, obesity, smoking, vaping, hospitalisation with COVID-19, deprivation, and being a healthcare worker are associated with higher probability of persistent symptoms in rounds 3–5, and Asian ethnicity with lower probability. Clustering analysis identifies a subset of participants with predominantly respiratory symptoms. Managing the long-term sequelae of COVID-19 will remain a major challenge for affected individuals and their families and for health services.
AU - Whitaker,M
AU - Elliott,J
AU - Chadeau,M
AU - Riley,S
AU - Darzi,A
AU - Cooke,G
AU - Ward,H
AU - Elliott,P
DO - 10.1038/s41467-022-29521-z
PY - 2022///
SN - 2041-1723
TI - Persistent COVID-19 symptoms in a community study of 606,434 people in England
T2 - Nature Communications
UR - http://dx.doi.org/10.1038/s41467-022-29521-z
UR - http://hdl.handle.net/10044/1/95785
VL - 13
ER -